| Product NDC: | 0591-3593 |
| Proprietary Name: | DRONABINOL |
| Non Proprietary Name: | DRONABINOL |
| Active Ingredient(s): | 10 mg/1 & nbsp; DRONABINOL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0591-3593 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018651 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940811 |
| Package NDC: | 0591-3593-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE, PLASTIC (0591-3593-60) |
| NDC Code | 0591-3593-60 |
| Proprietary Name | DRONABINOL |
| Package Description | 60 CAPSULE in 1 BOTTLE, PLASTIC (0591-3593-60) |
| Product NDC | 0591-3593 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DRONABINOL |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19940811 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | DRONABINOL |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |